Abstract
dc:descriptionExtracorporeal membrane lung support was first introduced a few decades ago, and quickly established itself as routine therapy in open heart surgery, whereas after a while it was also implemented in the treatment of severe respiratory failure. Despite the practicality and, above all, safety of membrane oxygenators, they are inherently encumbered with certain disadvantages, all directly associated with the membrane material. The diffusion of gas into blood through a membrane is diversely hampered by the intermediate strata of gas, liquid and solid. In the first half of this dissertation a novel method is presented, capable of reinforcing the driving force of diffusion, thus delivering enhanced gas transfer. The concept of hyperbaric oxygenation is by no means new, but its application in conventional extracorporeal gas exchange combined with recently introduced, purely diffusive membranes is first reported in this study. Diverse silicone membrane oxygenator modules were submitted to in vitro investigations under both normal and hyperbaric aeration conditions. The improvement in oxygen transfer rate (OTR) at hyperbaric operation verged on 30 % compared to normobaric aeration, using only a 40 % boost in total gas pressure. In fact, the performance gain from hyperbaric operation was sufficient to allow the smallest gas exchanger (0.7 m2) to perform virtually the same as a larger module with twice as much surface area at normobaric conditions. Finally, there was no gas bubble formation observed throughout this study. An adoption of this technology, particularly in tandem with purely diffusive membranes, could actually point towards surface reduction and oxygenator downsizing in general, which in turn would translate into a cost-efficient and overall performance-optimized treatment. Another crucial issue arising from the utilization of membranes in extracorporeal circulation (ECC) is material hemocompatibility, and by extension the instigation or promotion of blood trauma, oxidative stress and inflammation, particularly during long-term applications. Recently, molecular hydrogen (H2) has emerged as a potent antioxidative / anti-inflammatory agent and its therapeutic action has been thoroughly explored during the past decade. Although extensive effort has been dedicated in investigating hydrogen’s action against various diseases and conditions, including kidney failure and the pro-inflammatory influence of hemodialysis, little emphasis has been placed in researching the impact of hydrogen in extracorporeal gas exchange applications. In light of this, the second part of this dissertation concentrates on the administration of hydrogen gas during extracorporeal membrane oxygenation (ECMO) settings in a specially designed in vitro study. Five miniature ECMO circuits and a small vial acting as control were primed with heparinized blood from healthy adult donors (n = 7). Three of the ECMO systems were injected with lipopolysaccharide (LPS), out of which one was additionally treated with an H2 gas mixture. After 6 hours, samples were drawn for the assessment of specific biomarkers (MCP-1, MPO, MDA-a, TRX1, IL-6). The results indicate a progressive oxidative and inflammatory response between the 6 systems. Recirculation definitely triggered inflammation and hemolysis, as did LPS, but, remarkably, hydrogen was able to repress both, as evinced by the ameliorated hemolysis rate and biomarker concentrations in the H2-handled circuit. Future research should focus on distinct objectives, such as dosage/duration/cycle of H2 administration, in order to determine the optimal protocol for clinical application. Conclusively, both studies put forward innovative concepts for improved therapy outcome, higher quality of life, and reduced handling expenditures. Each of them offers an alternative perspective to the existing Extracorporeal Membrane Lung Support practices, highlighting the fact that there is still room for improvement.
Degree
thesis:*- Grantor dc:publisher
- Institutes outside Greece
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mouzakis, Foivos-Leonidas
- Μουζάκης, Φοίβος-Λεωνίδας
Subjects
dc:subject × 29- Εξωσωματική κυκλοφορία
- Ανταλλαγή αερίων αίματος
- Εξωσωματική οξυγόνωση μεμβράνης
- Διάχυση αερίων
- Υπερβαρική οξυγονοθεραπεία
- Μοριακό υδρογόνο
- Αντιφλεγμονώδης δράση
- Αντιοξειδωτικός παράγοντας
- Μεμβράνη σιλικόνης
- Extracorporeal circulation
- Gas exchange
- ECMO
- Gas diffusion
- Hyperbaric oxygen therapy
- Molecular hydrogen
- Anti-inflammatory action
- Antioxidant
- Silicone membrane
- Βιοϊατρική Μηχανική
- Επιστήμες Μηχανικού και Τεχνολογία
- Άλλες Ιατρικές Επιστήμες
- Ιατρική και Επιστήμες Υγείας
- Ιατρική έρευνα και Πειραματική ιατρική
- Medical Engineering
- Engineering and Technology
- Biomedical Engineering
- Other Medical Sciences
- Medical and Health Sciences
- Research and Experimental medicine
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/60976